MarketPeel
Insider Trading Intelligence
BL

Bcls Fund IV Investments, L.p.

KLRA
10% OWNER · KAILERA THERAPEUTICS, INC. · CIK 0002015454
FILING MIX · LIFETIME60%/40%
BUYS
3
SELLS
2
TOTAL VALUE
$25.00M
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
16,875,000
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Bcls Fund IV Investments, L.p.. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
KLRA · 16,875,000 shares · as of Apr 20, 2026
05,645,81711,291,63416,937,45122,583,268SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 3 buys / 2 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
KLRA
KAILERA THERAPEUTICS, INC.
SALE
16,875,0000Apr 20, 2026Apr 20, 2026
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
4,145,76821,020,768Apr 20, 2026Apr 20, 2026
KLRA
KAILERA THERAPEUTICS, INC.
SALE
4,145,7680Apr 20, 2026Apr 20, 2026
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
1,562,500$16.00$25.00M22,583,268Apr 20, 2026Apr 20, 2026
KLRA
KAILERA THERAPEUTICS, INC.
PURCHASE
16,875,00016,875,000Apr 20, 2026Apr 20, 2026
Other insiders · KLRA
Loading peer insiders…
About this filer
CIK 0002015454
ROLE
10% Owner
PRIMARY
KLRA
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002015454DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback